Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease
- 1 March 1994
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 73 (7), 456-459
- https://doi.org/10.1016/0002-9149(94)90675-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients.Circulation, 1993
- Simultaneous dobutamine stress echocardiography and technetium-99m isonitrile single-photon emission computed tomography in patients with suspected coronary artery diseaseJournal of the American College of Cardiology, 1993
- Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery.Circulation, 1993
- Dobutamine-induced ST segment elevation in a patient with angina at rest and critical coronary lesionsEuropean Heart Journal, 1992
- Safety of intravenous high-dose dipyridamole echocardiographyThe American Journal of Cardiology, 1992
- Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiographyThe American Journal of Cardiology, 1992
- Clinical significance of abrupt vasodepression during dobutamine stress echocardiographyThe American Journal of Cardiology, 1992
- Dobutamine stress echocardiography for detection and assessment of coronary artery diseaseJournal of the American College of Cardiology, 1992
- Accuracy of dobutamine stress echocardiography in detecting coronary artery diseaseThe American Journal of Cardiology, 1992
- Dobutamine stress echocardiography before and after coronary angioplastyThe American Journal of Cardiology, 1992